This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3c1x
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:3c1x. | + | {{Seed}} |
| + | [[Image:3c1x.png|left|200px]] | ||
<!-- | <!-- | ||
| Line 9: | Line 10: | ||
{{STRUCTURE_3c1x| PDB=3c1x | SCENE= }} | {{STRUCTURE_3c1x| PDB=3c1x | SCENE= }} | ||
| - | + | ===Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-MET in complex with a Pyrrolotriazine based inhibitor=== | |
| - | + | <!-- | |
| - | + | The line below this paragraph, {{ABSTRACT_PUBMED_18289854}}, adds the Publication Abstract to the page | |
| + | (as it appears on PubMed at http://www.pubmed.gov), where 18289854 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_18289854}} | ||
==Disease== | ==Disease== | ||
| Line 40: | Line 44: | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 16:11:35 2008'' | ||
Revision as of 13:11, 28 July 2008
Contents |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-MET in complex with a Pyrrolotriazine based inhibitor
Template:ABSTRACT PUBMED 18289854
Disease
Known disease associated with this structure: Hepatocellular carcinoma, childhood type OMIM:[164860], Renal cell carcinoma, papillary, familial and sporadic OMIM:[164860], Autism, suseptibility to, 9 OMIM:[164860]
About this Structure
3C1X is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase., Schroeder GM, Chen XT, Williams DK, Nirschl DS, Cai ZW, Wei D, Tokarski JS, An Y, Sack J, Chen Z, Huynh T, Vaccaro W, Poss M, Wautlet B, Gullo-Brown J, Kellar K, Manne V, Hunt JT, Wong TW, Lombardo LJ, Fargnoli J, Borzilleri RM, Bioorg Med Chem Lett. 2008 Mar 15;18(6):1945-51. Epub 2008 Feb 7. PMID:18289854
Page seeded by OCA on Mon Jul 28 16:11:35 2008
Categories: Homo sapiens | Receptor protein-tyrosine kinase | Single protein | Sack, J. | Atp-binding | Glycoprotein | Grb2 | Membrane | Nucleotide-binding | Phosphoprotein | Proto-oncogene | Receptor tyrosine kinase | Shc | Signal transduction | Transferase | Transmembrane | Tyrosine-protein kinase
